Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | BIRC2 | Q13490 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16866707 | 0.86 | ACHE (0.35) | CA1CA2ALDH1A1EPHX1NPSR1 | |
| SCHEMBL16870483 | 0.83 | ACHE (0.37) | ALDH1A1EPHX1ACHE | |
| SCHEMBL180793 | 0.81 | EPHX1 (0.36) | CA2ALDH1A1EPHX1NPSR1ACHE | |
| SCHEMBL13975291 | 0.81 | CA1 (0.40) | CA1CA2ZDHHC7HDAC2ALDH1A1 | |
| SCHEMBL26123695 | 0.81 | TSHR (0.38) | ALDH1A1LMNAHSD17B10KDM4EHPGD | |
| SCHEMBL3088096 | 0.80 | EPHX1 (0.50) | CA1CA2ALDH1A1EPHX1NPSR1 | |
| SCHEMBL28882351 | 0.78 | CA1 (0.42) | CA1CA2ZDHHC7HDAC2ALDH1A1 | |
| SCHEMBL28411727 | 0.78 | ACHE (0.40) | CA1CA2EPHX1ACHEHTT | |
| SCHEMBL16267378 | 0.77 | ACHE (0.39) | CA1CA2EPHX1ACHE | |
| SCHEMBL31121795 | 0.76 | ZDHHC7 (0.43) | CA1CA2ZDHHC7HDAC2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12611384-B2 | Antimicrobial nanoworms | THE BOEING COMPANY (US) | 2026-04-28 | — | — | US | disclosed |
| US-12534433-B2 | Antimicrobial compounds and nanostructures | THE BOEING COMPANY (US) | 2026-01-27 | — | — | US | disclosed |
| US-20250163348-A1 | A BLOCK COPOLYMER, PREPARATION PROCESS AND COMPOSITION THEREOF | BASF SE (DE) | 2025-05-22 | — | — | US | disclosed |
| EP-4499729-A1 | A BLOCK COPOLYMER, PREPARATION PROCESS AND COMPOSITION THEREOF | BASF SE (DE) | 2025-02-05 | — | — | EP | disclosed |
| EP-4324468-A1 | ANTIMICROBIAL COMPOUNDS AND NANOSTRUCTURES | The Boeing Company (US) | 2024-02-21 | — | — | EP | disclosed |
| EP-3638256-B1 | ANTIMICROBIAL COMPOUNDS AND NANOSTRUCTURES | BOEING CO (US) | 2023-11-22 | — | — | EP | disclosed |
| US-20230312468-A1 | ANTIMICROBIAL COMPOUNDS AND NANOSTRUCTURES | THE BOEING COMPANY | 2023-10-05 | — | — | US | disclosed |
| WO-2023180212-A1 | A BLOCK COPOLYMER, PREPARATION PROCESS AND COMPOSITION THEREOF | BASF SE (DE) | 2023-09-28 | — | — | WO | disclosed |
| US-11685715-B2 | Antimicrobial compounds and nanostructures | THE BOEING COMPANY (US) | 2023-06-27 | — | — | US | disclosed |
| US-20220331262-A1 | ANTIMICROBIAL NANOWORMS | THE BOEING COMPANY | 2022-10-20 | — | — | US | disclosed |
| US-9587104-B2 | Release media | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-03-07 | — | — | US | disclosed |
| US-20150337128-A1 | RELEASE MEDIA | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-11-26 | — | — | US | disclosed |
| US-20150337128-A1 | RELEASE MEDIA | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-11-26 | — | — | US | disclosed |
| US-20150337128-A1 | RELEASE MEDIA | THE UNIVERSITY OF QUEENSLAND (AU) | 2015-11-26 | — | — | US | disclosed |
| EP-2859088-A1 | RELEASE MEDIA | The University Of Queensland (AU) | 2015-04-15 | — | — | EP | disclosed |
| WO-2013181713-A1 | RELEASE MEDIA | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-12-12 | — | — | WO | disclosed |
| WO-2010118471-A1 | REACTOR AND METHOD FOR PERFORMING A CHEMICAL REACTION | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-10-21 | — | — | WO | disclosed |
| WO-2010118471-A1 | REACTOR AND METHOD FOR PERFORMING A CHEMICAL REACTION | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-10-21 | — | — | WO | disclosed |
| WO-2010091465-A1 | POLYMER PARTICLES | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010091465-A1 | POLYMER PARTICLES | THE UNIVERSITY OF QUEENSLAND (AU) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685715-B2 | Antimicrobial compounds and nanostructures | MPO, POLI, POLN | CA1 3507/4885CA2 1670/4885ZDHHC7 2338/4885 |
| US-20150337128-A1 | RELEASE MEDIA | CHMP4B, CRH, GRPR | CA1 1055/4885CA2 1244/4885ZDHHC7 4683/4885 |
| US-12534433-B2 | Antimicrobial compounds and nanostructures | MPO, TUBB1, BACH1 | CA1 3109/4885CA2 1289/4885ZDHHC7 3278/4885 |
| US-20230312468-A1 | ANTIMICROBIAL COMPOUNDS AND NANOSTRUCTURES | MPO, POLI, POLN | CA1 3507/4885CA2 1670/4885ZDHHC7 2338/4885 |
| US-20220331262-A1 | ANTIMICROBIAL NANOWORMS | DNPEP, MGAM, MASP2 | CA1 2933/4885CA2 4152/4885ZDHHC7 4104/4885 |
| US-12611384-B2 | Antimicrobial nanoworms | LCT, DNPEP, CLTA | CA1 1616/4885CA2 2133/4885ZDHHC7 4225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.